Point72 Asset Management, L.P.

Position in IMTX — Immatics N.V.

CIK 1603466 STAMFORD, CT

Position in IMTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$14,698,992

-$3,719,908 QoQ

Shares Held

1,493,800

-14.8% QoQ

Ownership

1.09%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $2,392,275,927 across 187 Biotechnology names. IMTX ranks #49 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APLS	Apellis Pharmaceuticals, Inc.	4,183,918	$168,319,021
2	MDGL	Madrigal Pharmaceuticals, Inc.	225,510	$118,047,719
3	CLDX	Celldex Therapeutics, Inc.	3,229,939	$102,453,665
4	RYTM	Rhythm Pharmaceuticals, Inc.	846,801	$73,646,282
5	AXSM	Axsome Therapeutics, Inc.	424,750	$71,791,245
6	ABVX	Abivax S.A.	637,736	$71,011,903
7	LEGN	Legend Biotech Corp	3,886,017	$70,298,047
8	JAZZ	Jazz Pharmaceuticals plc	358,634	$67,799,757

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$14,698,992	1,493,800	-14.8%	Shares	Defined	2026-05-15
2025-12-31	$18,418,900	1,754,181	+1384.2%	Shares	Defined	2026-02-17
2025-09-30	$1,006,970	118,189	+352.8%	Shares	Defined	2025-11-14
2024-09-30	$297,801	26,100	-61.1%	Shares	Defined	2024-11-14
2023-12-31	$705,667	67,015	-80.9%	Shares	Defined	2024-02-14
2023-09-30	$4,068,401	351,330	+4.3%	Shares	Defined	2023-11-14
2023-06-30	$3,885,679	336,714	-55.0%	Shares	Defined	2023-08-14
2023-03-31	$5,157,750	747,500	+130.0%	Shares	Defined	2023-05-15
2022-12-31	$2,830,750	325,000	+40.9%	Shares	Defined	2023-05-15
2022-09-30	$2,306,000	230,600	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.